Next Article in Journal
A Systematic Review and Meta-Analysis of the Direct Comparison of Second-Generation Cryoballoon Ablation and Contact Force-Sensing Radiofrequency Ablation in Patients with Paroxysmal Atrial Fibrillation
Next Article in Special Issue
Ultrasonographic Confirmation of Nasogastric Tube Placement in the COVID-19 Era
Previous Article in Journal
Prediction of Gastric Gastrointestinal Stromal Tumors before Operation: A Retrospective Analysis of Gastric Subepithelial Tumors
Previous Article in Special Issue
Professional Self-Concept and Self-Confidence for Nurses Dealing with COVID-19 Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

COVID-19 Vaccination Intention Associated with Behaviors towards Protection and Perceptions Regarding the Pandemic

by
Chrysoula Dafogianni
1,
Polyxeni Mangoulia
2,
Despoina Pappa
3,*,
Panagiota Xanthopoulou
4,
Ioannis Koutelekos
1,
Mixalis Zografakis-Sfakianakis
5,
Eftychia Ferentinou
6,
Antigoni Fountouki
7,
Marianna Drakopoulou
1,
Anna Giga
1,
Nikos Anastasiou
8,
Nikoletta Margari
1 and
Georgia Fasoi
1
1
Department of Nursing, University of West Attica, 12243 Athens, Greece
2
Department of Nursing Specialties and Education, Evangelismos General Hospital, 10676 Athens, Greece
3
Department of Nursing, University of West Attica & Henry Dunant Hospital Center, 12243 Athens, Greece
4
Faculty of Social Sciences, Hellenic Open University, 10677 Patras, Greece
5
Department of Nursing, Hellenic Mediterranean University, 71410 Crete, Greece
6
Department of Nursing, University of West Attica & Children Hospital “Agia Sofia”, 12243 Athens, Greece
7
Faculty of Nursing, International University of Greece, 57001 Thessaloniki, Greece
8
Central Clinic of Athens, 10680 Athens, Greece
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2022, 12(2), 295; https://doi.org/10.3390/jpm12020295
Submission received: 29 December 2021 / Revised: 10 February 2022 / Accepted: 13 February 2022 / Published: 17 February 2022
(This article belongs to the Special Issue Personalized Clinical and Community Nursing)

Abstract

:
Background: The impressively rapid availability of different types of COVID-19 vaccines and, on the other hand, the degree of their effectiveness as opposed to the likelihood of serious or non-serious side effects place a fairly large percentage of the population at a crossroads regarding the choice to get vaccinated or not, hence threatening achievement of total immunization coverage and full immunity. This study aimed to assess COVID-19 vaccination intention in Greece regarding protection behaviors and perceptions of the pandemic. Methods: A total of 3753 participants completed a specially designed electronic questionnaire anonymously and voluntarily. The study population consisted of healthcare workers, students, members of professional societies, teachers, and professors. The questionnaire was composed of four parts pertaining to demographic data and possible changes in hygiene attitudes during the COVID-19 pandemic. Results: In total, 43.3% of the participants stated that SARS-CoV-2 poses a significant risk. The most widespread protection practice was avoiding crowded places (90.1%), followed by reducing the use of public transport (86.1%) and washing their hands with soap and water more often than usual (84.2%). Women undertook significantly more behavioral changes than men and participants of other nationalities. About half of the participants (44%) implemented seven behavioral changes. Lower personal and general perceived risk due to COVID-19 was significantly associated with lower intention to get vaccinated. Conclusion: Strong hesitancy was observed towards COVID-19 vaccination. There is a need for further studies to be conducted to investigate the benefits and safety of vaccines for the purpose of better informing the public. Healthcare personnel can and should play a key role in this process.

1. Introduction

In December 2019, an acute atypical respiratory disease emerged in Wuhan city, Hubei province in mainland China. It was soon discovered that a novel coronavirus (SARS-CoV-2) was responsible. The coronavirus outbreak was officially declared a pandemic by the World Health Organization (WHO) [1] in March 2020 (coronavirus disease 2019—COVID-19—WHO, 2021), posing a significant threat to global public health.
The COVID-19 pandemic, an unprecedented phenomenon in the modern world, has affected every aspect of human activity and life around the globe. It is caused by severe acute respiratory syndrome coronavirus-2, or SARS-CoV-2, with cases ranging from individuals who are asymptomatic to those who experience severe respiratory distress and pneumonia and may even die [2]. Furthermore, the lack of targeted therapy continues to be a serious problem. The number of deaths caused by the disease is rising constantly worldwide. Many countries have been forced to take extreme measures, such as social distancing and lockdowns [3]. On the other hand, public engagement in health-protective behaviors, including social distancing and hygiene-related behaviors, is considered crucial to reduce the risk of infection and successfully manage the outbreak. A very important impact of the pandemic was the mental status of general population. There was disorientation with regards to the constant public threat; the insecurity of people’s jobs; and the repetition of pandemic news through the TV, the Internet, and social media, especially during lockdown policy when communication was affected. Thus, emotions became complex and daily motivations became fewer [4,5,6].
In the absence of an effective drug against SARS-CoV-2, the efforts of the international scientific community and researchers have been focused on the development of novel, safe, and effective vaccines. Just nine months after COVID-19 was declared a pandemic, the first vaccine was officially approved by the European Medicines Agency (E.M.A) [7] and the U.S. Food and Drug Administration (FDA) in late 2020 (Pfizer-BioNTech COVID-19 Vaccine, 2021). Vaccination against COVID-19 is currently the only available long-term solution to coronavirus disease 2019. However, although vaccines that reduce symptomatic disease have a crucial role in reducing the burden of COVID-19, vaccine hesitancy is a major barrier to vaccine uptake and the achievement of community (herd) immunity, which is required to protect the population, especially the most vulnerable persons [8].
With vaccines against COVID-19 now available to the public and vaccination programs in progress internationally, understanding the development and determinants of COVID-19 vaccination intentions among the public is vital. Meanwhile, a well-organized vaccination program is currently considered the most effective strategy against the COVID-19 outbreak [9,10]. According to Faasse and Newby [11], data from previous emerging infectious disease outbreaks highlight the role of several key factors in shaping engagement in health-protective behaviors and vaccination intentions. Recent scientific research, while showing that vaccine hesitancy is a global problem, also points out that that there is a quite large amount of people willing to be vaccinated.
The present study aimed to investigate vaccination intention in Greece and assess the prevailing attitude towards protective behaviors. An investigation focusing on the perceptions of the Greek population regarding this pandemic is of extreme importance given the economic and social upheavals it has caused both in Greece and worldwide.

2. Materials and Methods

2.1. Participants

Of the 3753 participants who completed the questionnaire, 3 did not meet the inclusion criteria and 56 were rejected because they did not meet the quality check criteria. The final sample was thus composed of 3694 participants (response rate = 98.5%).

2.2. Data Collection

The present study is a cross-sectional study performed through completion of a questionnaire with closed-ended questions. Random sampling was conducted from December 2020 to January 2021 among healthcare personnel, students, teachers, professors, and members of professional associations. The highest number of cases was 2185 infections just in the beginning of the research. On 9 January 2021, the total deaths were 5227, where the last questionnaire of the study was completed. Due to the COVID-19 pandemic and national restrictive measures, distribution and completion of the questionnaire was carried out electronically through personal emails; the process was conducted anonymously and voluntarily, and appropriate approval was previously obtained from the participants. During the study, Greek citizens were already applied in a restrictive measure, the so-called “lockdown’’ for the second time. Schools were also closed and any sport activity was suspended. After final submission of the answers, the questionnaire was automatically included in the electronic data files of the study. Issues of research ethics were applied after study protocol acceptance by the competent committees of the participating universities.

2.3. Instruments

In order to conduct the study, relevant questionnaires were employed to assess people’s perceptions of the pandemic and their intention regarding vaccination. Specifically, the questionnaire of Sherman et al. [12] was used to investigate attitudes and beliefs not only concerning other vaccines but also COVID-19 itself and COVID-19 vaccination, specifically. Furthermore, the questionnaire of Seale et al. [13], developed for vaccination against H1N1 in 2009, was also applied in this research project. The questions were assessed and adjusted appropriately. This tool consisted of four parts, as detailed below.
Firstly, demographic and personal data were recorded, namely, age, gender, education level, total family income, religion, and place of residence.
The second part contained questions about participants’ beliefs concerning COVID-19 disease and, specifically, whether they considered it dangerous or not. The 10-point Likert scale was used to show the population’s level of agreement concerning specific tool items.
The third part of the tool comprised 24 questions related to participants’ beliefs as to the possible advantages of COVID-19 vaccination, their reasons for mistrust of the vaccination, and their perceived self-efficacy and behavioral control.
The final part included eight questions regarding behavior change due to the COVID-19 outbreak related to hygiene habits and daily activities. It would be useful to mention that during the research, the only available option for COVID-19 vaccination was the Pfizer/Biontech shot for healthcare professionals. At the final phase of the study, Greece obtained approval for the Moderna vaccine but it was deployed a few days later [14].

2.4. Data Analysis

Quantitative variables were expressed as the mean (standard deviation) or as the median (interquartile range). Qualitative variables were expressed as absolute and relative frequencies. Multiple linear regression analysis was conducted in order to find independent factors associated with the number of behavioral changes adopted due to the pandemic and participants’ intention to get vaccinated against COVID-19.
Participants’ demographics and their perceptions of the COVID-19 pandemic were used as independent variables.
In the event that the intention to get vaccinated was the dependent variable, implementing at least one behavioural change was entered in the analysis as an independent variable. Adjusted regression coefficients (β) (or beta coefficients) and their confidence intervals were derived from the analyses. Due to the large number of predictors in the model, statistical significance was set at p < 0.01. Assumptions about the analysis were checked. All reported p values were two-tailed. Analyses were conducted using SPSS statistical software (version 22.0).

3. Results

3.1. Demographic Characteristics

The sample consisted of 3697 participants (67.7% females), with a mean age of 29.4 years (SD = 12.6 years) from 2 December 2020 to 9 January 2021. Most of the participants were Greek nationals and Christian Orthodox, with the percentages being 96.5% and 76.8%, respectively (Table 1). In addition, 48.8% of the participants were high school graduates, 37.7% were key workers in the pandemic, and 24.1% had an annual income of up to EUR 10,000. Furthermore, 57.4% of the participants were living with two to three people in the same household and 70.3% were living in Athens. Lastly, 72.2% of the participants had not been vaccinated against seasonal flu during the previous winter.

3.2. Perceptions toward Protection and COVID-19 Vaccination Intention

As far as the perceived risk from COVID-19 for the population of Greece is concerned, 43.3% of the participants stated that it is significant (Table 2). Personal risk from COVID-19 was considered to be moderate among 27.7% of the participants. A total of 39.2% of the participants had not had, and did not currently have, COVID-19, and 70.6% personally knew someone who had had it or who currently had it. As mentioned above, total deaths from COVID-19 were 5227 already. Lastly, 36.4% of the participants thought that their employer would want them to have the COVID-19 vaccination, and 32.2% knew that there is currently a widely available vaccination to protect against the virus. However, the only choice of vaccine type in Greece during that period was Pfizer/Biontech for healthcare workers. Announcements from the Ministry of Health were about the imminent start of the vaccination rollout with the Moderna vaccine on February 2021 to the general population over 85 years old.
Participants’ responses regarding their behavior due to the COVID-19 pandemic are presented in Table 3. The most common practice reported was avoiding crowded places (90.1%), followed by reducing the amount they use public transport and washing their hands with soap and water more often than usual (86.1% and 84.2%, respectively). Almost all the participants (98.4%) made at least one behavioral change due to the COVID-19 pandemic. The number of behavioral changes due to the COVID-19 pandemic ranged from 0 to 8, with the mean being 5.9 (SD = 1.7). About half of the participants (44%) implemented seven behavioral changes (Figure 1).
Women made significantly more behavioral changes compared to men (Table 4). On the other hand, participants who were not of Greek nationality and participants who were living abroad made significantly fewer behavioral changes. Moreover, age and the number of people living in the same household as the participants were significantly and positively associated with the number of behavioral changes adopted. Furthermore, as perceived general risk due to the pandemic decreased with the passage of time, the number of behavioral changes accordingly diminished significantly. As far as perceived personal risk was concerned, it was found that participants who thought they had minor or no personal risk undertook significantly fewer behavioral changes in comparison to those who felt that they ran a major personal risk. Knowing someone personally who previously or currently had COVID-19 was significantly associated with implementing more behavioral changes.
The intention to get vaccinated against COVID-19 ranged from 0 (strongly disagree) to 10 (strongly agree), with the mean value being 5.6 (SD = 3.6) and the median being 6 (IQR: 2–9). A significantly lower intention to get vaccinated against COVID-19 was demonstrated by women and Christian Orthodox participants (Table 5). In contrast, participants living outside Athens had significantly greater intention to get vaccinated, as did those who had been vaccinated against seasonal flu during the previous year. Lower personal and general perceived risk due to COVID-19 was significantly associated with lower intention to get vaccinated. Those who personally knew someone who previously or currently had COVID-19 and those who made at least one behavioral change were significantly associated with higher intention to get vaccinated.

4. Discussion

The present study investigated COVID-19 vaccination intention associated with behaviors towards protection and perceptions regarding the pandemic. Almost all of the participants undertook at least one behavioral change due to the COVID-19 pandemic and half of them seven behavioral changes, such as washing their hands more frequently with soap. The most common practice reported was avoiding crowded places, followed by reducing use of public transport and washing their hands with soap and water more often than usual. Female gender, age, and the number of people living in the same household as the participant were significantly and positively associated with the number of behavioral changes.
Similar results were presented by Dafogianni et al. [15] in a survey of 130 Greek nurses, whereby the great majority of participants reported that they apply measures to help prevent the spread of COVID-19 at home. This might be due to the fact that the majority of participants were married with children and faced a responsibility to protect their family members. In the same study, the most frequent coping strategies were acceptance of reality, serious consideration of the next step, and an attempt to see the situation differently and more positively or seeking something positive in the situation. Older age was more strongly correlated with active/positive coping.
The COVID-19 pandemic has globally imposed a heavy burden of disease on all countries and health systems, as there were no specific antiviral treatments for SARS-CoV-2 at the time [16,17,18]. As immunization is one of the most successful and cost-effective health interventions to prevent and control infectious diseases, vaccines against COVID-19 are of crucial importance [19,20]. Thus, countries worldwide are endeavoring to accelerate research into the development of COVID-19 vaccines. Around the world, there are now 135 COVID-19 vaccine candidates undergoing clinical trials and 194 candidates in pre-clinical development.
Previous reports on the acceptance and uptake of pandemic vaccines have shown unsatisfying results. For example, in the case of the 2009 H1N1 pandemic, the general public’s willingness to receive the H1N1 pandemic vaccine was reported to have ranged from 17% to 67% across studies from Australia, the U.S.A., Greece, the U.K., and France [21,22,23,24,25,26,27]. As concerns around vaccines used against new emerging pandemics, including the 2009 H1N1 pandemic, are novel, public concern about vaccine safety has frequently been identified as a serious barrier to vaccine acceptance [20,23,24,27,28,29], while attitudes and past history regarding vaccination, especially the history of influenza vaccination, were the main predictors of pandemic vaccine uptake [20,21,22,25,27,28,29,30,31,32].
In this study, the mean value of intention to be vaccinated against COVID-19 was 5.6±3.6. Male gender and living outside the city of Athens were positively correlated with the intention to get vaccinated against COVID-19. Perceived personal risk and knowing someone who had had or who currently had the virus were significantly associated with undertaking more behavioral changes and greater intention to get vaccinated. Women accounted for the vast majority of this study’s respondents, suggesting that COVD-19 vaccine hesitancy could be greater in real life settings.
In a study by Wang et al. [33] on 2058 participants in China, more than half of respondents wanted to get vaccinated as soon as possible, while others intended to delay the vaccination until they had confirmed the safety of the vaccine. Among respondents who accepted vaccination, the most significant factors influencing their vaccination acceptance were the following: male gender, marital status, risk perception, history of influenza vaccination, belief in COVID-19 vaccine efficacy, valuing one’s doctor’s recommendations, vaccination convenience, and vaccine price (where applicable, e.g., some early regional cases in China) [34,35]. On the other hand, the population in Greece then had the only choice for one type of vaccination, the mRNA vaccine. Several cases of adverse events followed by vaccination came up globally, worrying both scientists as well as people who were thinking of being vaccinated. Thrombosis, myocarditis, blood clots with low platelets, or even death were described in literature as possible side effects from vaccines. This situation increased population’s hesitancy surrounding mRNA vaccines, viral vectors vaccines, and other types of them that were finally approved after the study period [7].
In a multi-methods study in the U.K. on 1252 parents and guardians, most participants also reported they would like to receive COVID-19 vaccination for themselves and for their children. Participants who self-reported as Black, Asian, Chinese, mixed, or other ethnicity were almost three times more likely to reject a COVID-19 vaccine for themselves and their children than White British, White Irish, and other White participants [36]. This result is in contrast to that of the present study, in which Christian Orthodox participants had lower intention of getting vaccinated. However, the latter could be due to differences in the questions asked, highlighting the need for cross-country surveys and consistency in the wording of questions. Another reason could be the timeline in which the survey was conducted. Generally speaking, ethnicity and religious beliefs seem to play role in people’s intention to get vaccinated.
The present study also confirmed the positive role of influenza vaccination history and the belief in vaccine effectiveness in accepting immediate vaccination for COVID-19, which was consistent with that of previous studies [20,21,22,25,27,28,30]. Furthermore, respondents’ risk perception was an important predictor of vaccination acceptance, which was also found in other studies [31,34,35]. In the study by Detoc et al. [36] in 3259 individuals, male gender and older age were not associated with perceived individual risk, but rather with fears surrounding COVID-19. In the same vein, healthcare workers were more likely to get vaccinated or to participate in a vaccine clinical trial than the other participants. They hypothesized that healthcare workers are particularly vulnerable, while they were aware that, for instance, the latter social group accounted for 10% of those infected in Italy and in Greece [37,38]. Nurses and assistant nurses were less willing to accept vaccination against COVID-19 than physicians. Vaccine hesitancy was associated with a decrease in COVID-19 acceptance [39]. Although most medical students perceived the importance of the COVID-19 vaccine [39], almost half of the medical and nursing students were vaccine-hesitant [40,41,42].
In the present study, only one-third of the participants knew that there is currently a widely available vaccination to protect against SARS-CoV-2. Earnshaw et al.’s study [43], on 845 U.S. adults in April 2020, noted that one-third of participants believed one or more conspiracy theories about COVID-19. It was also found that intention to get vaccinated was 3.9 times lower among participants who believed in conspiracy theories, while these individuals additionally indicated less support for COVID-19 public health policies than participants who did not believe in conspiracy theories.
The aforementioned surveys show that the difference in vaccination acceptance varies greatly between countries, from around 62% in France to 80% in Denmark and the U.K. [44] and is reflective of trust in vaccines and healthcare systems more broadly as well as in governments [35]. Two recent U.S. studies on this issue indicated that the potential acceptance of the prospective COVID-19 vaccines ranged from 57.6% to 68.8% [45,46]. A recent global survey involving 19 countries reported a less than 55% acceptance rate in Russia, with the highest rate being in China at 90% [47]. Sallam et al. [48] reported that only 29.4% of the respondents in Jordan, Kuwait, and other Arab countries would get vaccinated against COVID-19. This rate, which appears to be among the lowest acceptance rates globally, is alarming [49].
Chevallier, Hacquin, and Mercier [50] offer three recommendations to increase COVID-19 vaccination rates, as follows: first, implementation of communication campaigns utilizing evidence-based levers and argumentation tools provided by experts; second, the use of behavioral insights to make vaccination more accessible; and third, helping early adopters to communicate about their decision to be vaccinated so as to accelerate the emergence of pro-vaccination norms.
Our study has several limitations. First, the online survey may have limited the representativeness of the study sample; however, in an attempt to address this problem, a large sample size and a random sampling method were used. Moreover, some self-reported answers may lead to information bias, while the study results may differ from real practice and may change over time.

5. Conclusions

Vaccine hesitancy remains high during the current COVID-19 pandemic, with slow rates of vaccination being registered during the first half of 2021. Vaccine availability and efficiency towards the COVID-19 pandemic had a serious impact on vaccination intention. Several reasons have been stated by the participants for vaccine refusal during this period. It is evident that further studies are needed to investigate the levels of acceptance of COVID-19 vaccination and people’s perceptions during different phases of the pandemic and the reasons why vaccine efficacy and safety are not taken more seriously into consideration. Health professionals should be involved to support the public and help with informed decision making as regards acceptance of vaccinations.

Author Contributions

Conceptualization, C.D.; methodology, C.D., I.K., M.Z.-S., M.D. and N.M.; analysis, C.D. and P.X.; data curation, C.D., P.M., P.X., D.P. and A.G.; writing—original draft preparation, P.X., P.M., D.P., E.F. and A.G.; writing—review and editing, C.D., P.X., P.M., D.P., N.A., G.F., A.F. and A.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The present study was approved by the Hellenic Open University.

Informed Consent Statement

Informed consent was obtained from all study participants of the survey.

Data Availability Statement

All the data generated during this study are included in this published article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report—66. 2019. Available online: https://www.who.int/docs/default-source/coronavirus/situation-reports/20200326-sitrep-66-covid-19.pdf?sfvrsn=9e5b8b48_2 (accessed on 26 March 2020).
  2. Reiter, P.L.; Pennell, M.L.; Katz, M.L. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine 2020, 38, 6500–6507. [Google Scholar] [CrossRef]
  3. Yuki, K.; Fujiogi, M.; Koutsogiannaki, S. COVID-19 pathophysiology: A review. Clin. Immunol. 2020, 215, 108427. [Google Scholar] [CrossRef]
  4. Barsade, S.G.; Coutifaris, C.G.; Pillemer, J. Emotional contagion in organizational life. Res. Organ. Behav. 2018, 38, 137–151. [Google Scholar] [CrossRef]
  5. Frijda, N.H. Impulsive action and motivation. Biol. Psychol. 2010, 84, 570–579. [Google Scholar] [CrossRef] [PubMed]
  6. de Vignemont, F.; Singer, T. The empathic brain: How, when and why? Trends Cogn. Sci. 2006, 10, 435–441. [Google Scholar] [CrossRef] [Green Version]
  7. EMA COVID-19 Vaccine Janssen: EMA Finds Possible Link to very Rare Cases of Unusual Blood Clots with Low Blood Platelets. Available online: https://www.ema.europa.eu/en/news/covid-19-vaccine-janssen-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood (accessed on 8 February 2022).
  8. Cavaleri, M.; Sweeney, F.; Gonzalez-Quevedo, R.; Carr, M. Shaping EU Medicines Regulation in the Post COVID-19 Era; The Lancet Regional Health-Europe: Munich, Germany, 2021; Volume 9, p. 100192. ISSN 2666–7762. [Google Scholar] [CrossRef]
  9. Schaffer DeRoo, S.; Pudalov, N.J.; Fu, L.Y. Planning for a COVID-19 Vaccination Program. JAMA 2020, 323, 2458–2459. [Google Scholar] [CrossRef] [PubMed]
  10. Zampetakis, L.A.; Melas, C. The health belief model predicts vaccination intentions against COVID-19: A survey experiment approach. Appl. Psychol. Health Well Being 2021, 13, 469–484. [Google Scholar] [CrossRef] [PubMed]
  11. Newby, J.M.; O’Moore, K.; Tang, S.; Christensen, H.; Faasse, K. Acute mental health responses during the COVID-19 pandemic in Australia. PLoS ONE 2020, 15, e0236562. [Google Scholar] [CrossRef] [PubMed]
  12. Sherman, S.M.; Smith, L.E.; Sim, J.; Amlôt, R.; Cutts, M.; Dasch, H.; Rubin, G.J.; Sevdalis, N. COVID-19 vaccination intention in the UK: Results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum. Vaccin Immunother. 2021, 17, 1612–1621. [Google Scholar] [CrossRef]
  13. Seale, H.; McLaws, M.-L.; Heywood, A.E.; Ward, K.F.; Lowbridge, C.P.; Van, D.; Gralton, J.; MacIntyre, C.R. The community’s attitude towards swine flu and pandemic influenza. Med. J. Aust. 2009, 191, 267–269. [Google Scholar] [CrossRef]
  14. Maltezou, H.C.; Krumbholz, B.; Mavrouli, M.; Tseroni, M.; Gamaletsou, M.N.; Botsa, E.; Anastassopoulou, C.; Gikas, A.; Fournarakou, E.; Kavieri, M.; et al. A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021. J. Med. Virol. 2021, 1–8. [Google Scholar] [CrossRef] [PubMed]
  15. Dafogianni, C.; Pappa, D.; Koutelekos, I.; Mangoulia, P.; Ferentinou, E.; Margari, N. Stress, anxiety, and depression in nurses during COVID-19 pandemic: Evaluation of coping strategies. Int. J. Nurs. 2021, 8, 1–10. [Google Scholar]
  16. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
  17. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available online: https://covid19.who.int/?gclid=EAIaIQobChMI2_CM6eDZ6gIVghh9Ch3nDQm1EAAYASAAEgLqwPD_BwE (accessed on 20 May 2021).
  18. World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. Available online: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (accessed on 20 May 2021).
  19. Lurie, N.; Saville, M.; Hatchett, R.; Halton, J. Developing COVID-19 Vaccines at Pandemic Speed. N. Engl. J. Med. 2020, 382, 1969–1973. [Google Scholar] [CrossRef]
  20. Yang, Y.; Peng, F.; Wang, R.; Guan, K.; Jiang, T.; Xu, G.; Sun, J.; Chang, C. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun. 2020, 109, 102434. [Google Scholar] [CrossRef]
  21. World Health Organization. DRAFT Landscape of COVID-19 Candidate Vaccines—28 May 2021. Available online: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (accessed on 28 May 2021).
  22. Eastwood, K.; Durrheim, D.N.; Jones, A.; Butler, M. Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. Med. J. Aust. 2010, 192, 33–36. [Google Scholar] [CrossRef]
  23. Maurer, J.; Harris, K.M.; Parker, A.M.; Lurie, N. Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: Evidence from a nationally representative survey of U.S. adults. Vaccine 2009, 27, 5732–5734. [Google Scholar] [CrossRef] [Green Version]
  24. Schwarzinger, M.; Flicoteaux, R.; Cortarenoda, S.; Obadia, Y.; Moatti, J.P. Low acceptability of A/H1N1 pandemic vaccination in French adult population: Did public health policy fuel public dissonance? PLoS ONE 2010, 5, e10199. [Google Scholar] [CrossRef]
  25. Maurer, J.; Uscher-Pines, L.; Harris, K.M. Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: Does the source of information matter? Prev. Med. 2010, 51, 185–187. [Google Scholar] [CrossRef]
  26. Sypsa, V.; Livanios, T.; Psichogiou, M.; Malliori, M.; Tsiodras, S.; Nikolakopoulos, I.; Hatzakis, A.A. Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: Evidence from a cross-sectional telephone survey. Eur. Surveill. 2009, 14, 19437. [Google Scholar] [CrossRef]
  27. Raude, J.; Caille-Brillet, A.L.; Setbon, M. The 2009 pandemic H1N1 influenza vaccination in France: Who accepted to receive the vaccine and why? PLoS Curr. 2010, 2, RRN1188. [Google Scholar] [CrossRef] [PubMed]
  28. Rubin, G.J.; Potts, H.; Michie, S. The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: Results from 36 national telephone surveys in the UK. Health Technol. Assess. 2010, 14, 183–266. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Seale, H.; Heywood, A.E.; McLaws, M.L.; Ward, K.F.; Lowbridge, C.P.; Van, D.; MacIntyre, C.R. Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect. Dis. 2010, 10, 99. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Nguyen, T.; Henningsen, K.H.; Brehaut, J.C.; Hoe, E.; Wilson, K. Acceptance of a pandemic influenza vaccine: A systematic review of surveys of the general public. Infect. Drug Resist. 2011, 4, 197–207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Henrich, N.; Holmes, B. The public’s acceptance of novel vaccines during a pandemic: A focus group study and its application to influenza H1N1. Emerg Health Threat J. 2009, 2, e8. [Google Scholar] [CrossRef]
  32. Lau, J.T.F.; Yeung, N.C.; Choi, K.C.; Cheng, M.Y.; Tsui, H.; Griffiths, S. Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population. Vaccine 2010, 28, 4632–4637. [Google Scholar] [CrossRef]
  33. Wang, J.; Jing, R.; Lai, X.; Zhang, H.; Lyu, Y.; Knoll, M.D.; Fang, H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines 2020, 8, 482. [Google Scholar] [CrossRef]
  34. Reuters. China to Provide COVID-19 Vaccines Free of Charge–Official. Available online: https://www.reuters.com/article/uk-health-coronavirus-china-vaccine-idUKKBN29E04Z (accessed on 10 December 2021).
  35. Bell, S.; Clarke, R.; Mounier-Jack, S.; Walker, J.L.; Paterson, P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine 2020, 38, 7789–7798. [Google Scholar] [CrossRef]
  36. Detoc, M.; Bruel, S.; Frappe, P.; Tardy, B.; Botelho-Nevers, E.; Gagneux-Brunon, A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine 2020, 38, 7002–7006. [Google Scholar] [CrossRef]
  37. Determann, D.; de Bekker-Grob, E.W.; French, J.; Voeten, H.A.; Richardus, J.H.; Das, E.; Korfage, I.J. Future pandemics and vaccination: Public opinion and attitudes across three European countries. Vaccine 2016, 34, 803–808. [Google Scholar] [CrossRef] [Green Version]
  38. Chirico, F.; Nucera, G.; Magnavita, N. COVID-19: Protecting healthcare workers is a priority. Infect. Control Hosp. Epidemiol. 2020, 41, 1–4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Maltezou, H.C.; Dedoukou, X.; Tseroni, M.; Tsonou, P.; Raftopoulos, V.; Papadima, K.; Mouratidou, E.; Poufta, S.; Panagiotakopoulos, G.; Hatzigeorgiou, D.; et al. SARS-CoV-2 infection in healthcare personnel with high-risk occupational exposure: Evaluation of seven-day exclusion from work policy. Clin Infect Dis. 2020, 71, ciaa888. [Google Scholar] [CrossRef] [PubMed]
  40. Gagneux-Brunon, A.; Detoc, M.; Bruel, S.; Tardy, B.; Rozaire, O.; Frappe, P.; Botelho-Nevers, E. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: A cross-sectional survey. J. Hosp. Infect. 2020, 108, 168–173. [Google Scholar] [CrossRef]
  41. Saied, S.M.; Saied, E.M.; Kabbash, I.A.; El-Fatah Abdo, S.A. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J. Med. Virol. 2021, 93, 4280–4291. [Google Scholar] [CrossRef] [PubMed]
  42. Manning, M.L.; Gerolamo, A.M.; Marino, M.A.; Hanson-Zalot, M.E.; Pogorzelska-Maziarz, M. COVID-19 vaccination readiness among nurse faculty and student nurses. Nurs. Outlokk. 2021, 69, 565–573. [Google Scholar] [CrossRef] [PubMed]
  43. Earnshaw, V.A.; Eaton, L.A.; Kalichman, S.C.; Brousseau, N.M.; Hill, E.C.; Fox, A.B. COVID-19 conspiracy beliefs, health behaviors, and policy support. Trans. Behav. Med. 2020, 10, 850–856. [Google Scholar] [CrossRef]
  44. Neuman-Böhme, S.; Varghese, N.E.; Sabat, I. Once we have it, it will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur. J. Health Econ. 2020, 21, 977–982. [Google Scholar] [CrossRef]
  45. Pogue, K.; Jensen, J.L.; Stancil, C.K.; Ferguson, D.G.; Hughes, S.J.; Mello, E.J.; Burgess, R.; Berges, B.K.; Quaye, A.; Poole, B.D. Influences on attitudes regarding potential COVID-19 vaccination in the United States. Vaccines 2020, 8, 582. [Google Scholar] [CrossRef]
  46. Fisher, K.A.; Bloomstone, S.J.; Walder, J.; Crawford, S.; Fouayzi, H.; Mazor, K.M. Attitudes toward a potential SARS-CoV-2 vaccine: A survey of U.S. adults. Ann. Intern. Med. 2020, 173, 964–973. [Google Scholar] [CrossRef]
  47. Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2021, 27, 225–228. [Google Scholar] [CrossRef]
  48. Sallam, M.; Dababseh, D.; Eid, H.; Al-Mahzoum, K.; Al-Haidar, A.; Taim, D.; Yaseen, A.; Ababneh, N.A.; Bakri, F.G.; Mahafzah, A. High rates of CVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries. Vaccines 2021, 9, 42. [Google Scholar] [CrossRef] [PubMed]
  49. Sallam, M. COVID-19 vaccine hesitancy worldwide: A systematic review of vaccine acceptance rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef] [PubMed]
  50. Chevallier, C.; Hacquin, A.S.; Mercier, H. COVID-19 vaccine hesitancy: Shortening the last mile. Trends Cogn. Sci. 2021, 25, 331–333. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The number of behavioral changes due to the COVID-19 pandemic. The number of behavioral changes due to the COVID-19 pandemic.
Figure 1. The number of behavioral changes due to the COVID-19 pandemic. The number of behavioral changes due to the COVID-19 pandemic.
Jpm 12 00295 g001
Table 1. Sample characteristics.
Table 1. Sample characteristics.
n (%)
GenderMale1193 (32.3)
Female2498 (67.7)
Age, mean (SD)29.4 (12.6)
NationalityGreek3566 (96.5)
Other110 (3.0)
Prefer not to say18 (0.5)
ReligionChristian Orthodox2821 (76.8)
No religion329 (9.0)
Other90 (2.4)
Don’t know1 (0.0)
Prefer not to say432 (11.8)
Educational levelPrimary school1 (0.0)
High school1802 (48.8)
University1155 (31.3)
MSc degree661 (17.9)
Prefer not to say70 (1.9)
Key worker 1395 (37.7)
Annual incomeEUR ≤ 10,000869 (24.1)
EUR 10,001–20,000783 (21.7)
EUR 20,001–30,000240 (6.6)
EUR 30,001–40,000104 (2.9)
EUR 40,001–50,00055 (1.5)
EUR 50,001–75,00035 (1)
>75,00028 (0.8)
Don’t know723 (20.0)
Prefer not to say776 (21.5)
Number of people in household1377 (10.2)
2684 (18.6)
3–42114 (57.4)
5–6428 (11.6)
>737 (1)
Prefer not to say43 (1.2)
ResidenceAthens/Attica2569 (70.3)
Outside Athens1036 (28.4)
Abroad48 (1.3)
Flu vaccination last winterNo2665 (72.2)
Yes909 (24.6)
Don’t know104 (2.8)
Prefer not to say15 (0.4)
Table 2. Descriptive statistics for items measuring participants’ perceptions of the COVID-19 pandemic * not entered in the analysis.
Table 2. Descriptive statistics for items measuring participants’ perceptions of the COVID-19 pandemic * not entered in the analysis.
ItemLeveln (%)
To what extent do you think COVID-19 poses a risk to people in Greece?Major risk1090 (29.5)
Significant risk1601 (43.3)
Moderate risk733 (19.8)
Minor risk220 (6.0)
No risk at all26 (0.7)
Don’t know25 (0.7)
To what extent do you think COVID-19 poses a risk to you personally?Major risk525 (14.2)
Significant risk884 (23.9)
Moderate risk1022 (27.7)
Minor risk997 (27.0)
No risk at all231 (6.3)
Don’t know37 (1.0)
Do you believe you have had, or currently have, COVID-19? *Definitely99 (2.7)
Probably269 (7.3)
Probably not1371 (37.1)
Definitely not1448 (39.2)
Don’t know504 (13.6)
Prefer not to say5 (0.1)
Do you personally know anyone (excluding yourself) who has had COVID-19?No1076 (29.2)
Yes2608 (70.6)
Prefer not to say9 (0.2)
As far as you know, would your employer want you to have the COVID-19 vaccination? *No184 (5.1)
Yes1315 (36.4)
Don’t know1634 (45.3)
Prefer not to say477 (13.2)
As far as you know, is there currently a widely available vaccination to protect against COVID-19? *No1550 (42.3)
Yes1180 (32.2)
Don’t know829 (22.6)
Prefer not to say107 (2.9)
Table 3. Behavioral responses to COVID-19 pandemic.
Table 3. Behavioral responses to COVID-19 pandemic.
n (%)
Washed my hands with soap and water more often than usual3112 (84.2)
Used alcoholic hand gel more than usual3013 (81.6)
Increased the amount I clean or disinfect things that I might touch, such as door knobs2645 (71.6)
Kept away from crowded places generally3343 (90.5)
Reduced the amount I use public transport3180 (86.1)
Deliberately cancelled or postponed a social event, such as meeting friends, eating out, or going to a sports event2893 (78.3)
Reduced the amount I go into shops2980 (80.7)
Kept one or more of my children out of school or preschool226 (42.6)
Undertook ≥ 1 behavioral change due to the COVID-19 pandemic3637 (98.4)
Number of behavioral changes due to the COVID-19 pandemic, mean (SD)5.9 (1.7)
Table 4. Multiple regression analysis results with number of behavioral changes due to the COVID-19 pandemic as dependent variable, and participants’ characteristics and their perceptions of the COVID-19 pandemic as independent variables. Note. The model was based on 2863 cases with complete data. * p < 0.01; ** p < 0.001.
Table 4. Multiple regression analysis results with number of behavioral changes due to the COVID-19 pandemic as dependent variable, and participants’ characteristics and their perceptions of the COVID-19 pandemic as independent variables. Note. The model was based on 2863 cases with complete data. * p < 0.01; ** p < 0.001.
Unstandardized
Coefficient β
Standardized
Coefficient β
99% CI for βp Value
Gender (reference: Men)0.200.050.05 to 0.360.001 *
Age0.010.070.00 to 0.020.001 *
Nationality (reference: Greek)−0.79−0.07−1.23 to −0.34<0.001 **
Key worker−0.02−0.01−0.18 to 0.140.738
Religion (reference: No religion)
 Christian Orthodox−0.09−0.02−0.32 to 0.150.343
 Other−0.010.00−0.51 to 0.480.940
Number of people in household0.090.050.01 to 0.180.005 *
Residence (reference: Athens/Attica)
Outside Athens0.070.02−0.09 to 0.230.267
Abroad−0.64−0.04−1.26 to −0.020.008 *
Flu vaccination last winter (reference: No)0.100.03−0.07 to 0.280.129
To what extent do you think COVID-19 poses a risk to people in Greece? (reference: Major risk)
 No risk at all/minor risk−2.39−0.34−2.75 to −2.03<0.001 **
 Moderate risk−1.09−0.25−1.35 to −0.83<0.001 **
 Significant risk−0.33−0.09−0.52 to −0.13<0.001 **
To what extent do you think COVID-19 poses a risk to you personally? (reference: Major risk)
 No risk at all/minor risk−0.57−0.15−0.87 to −0.27<0.001 **
 Moderate risk−0.09−0.02−0.36 to 0.180.382
 Significant risk0.060.02−0.18 to 0.310.495
Do you personally know anyone (excluding yourself) who has had COVID-19? (reference: No)0.240.060.08 to 0.40<0.001 **
Table 5. Multiple regression analysis results with intention to get vaccinated against COVID-19 as a dependent variable, and participants’ characteristics, their perceptions of the COVID-19 pandemic, and adopting at least one behavioral change due to the COVID-19 pandemic as independent variables. Note. The model was based on 2863 cases with complete data. * p < 0.01; ** p < 0.001.
Table 5. Multiple regression analysis results with intention to get vaccinated against COVID-19 as a dependent variable, and participants’ characteristics, their perceptions of the COVID-19 pandemic, and adopting at least one behavioral change due to the COVID-19 pandemic as independent variables. Note. The model was based on 2863 cases with complete data. * p < 0.01; ** p < 0.001.
Unstandardized
Coefficient β
Standardized
Coefficient β
99% CI for βp Value
Gender (reference: Men)−0.55−0.07−0.88 to −0.23<0.001 **
Age−0.01−0.02−0.02 to 0.010.294
Nationality (reference: Greek)0.710.03−0.22 to 1.630.050
Key worker−0.06−0.01−0.39 to 0.260.616
Religion (reference: No religion
 Christian Orthodox−1.35−0.13−1.83 to −0.86<0.001 **
 Other−0.58−0.03−1.6 to 0.440.141
Number of people in household−0.010.00−0.19 to 0.170.914
Residence (reference: Athens / Attica)
Outside Athens0.360.050.03 to 0.690.005 *
Abroad0.280.01−1.01 to 1.570.576
Flu vaccination last winter (reference: No)1.170.140.81 to 1.53<0.001 **
To what extent do you think COVID-19 poses a risk to people in Greece? (reference: Major risk)
 No risk at all/minor risk−4.96−0.34−5.72 to −4.2<0.001 **
 Moderate risk−3.14−0.34−3.67 to −2.6<0.001 **
 Significant risk−1.48−0.20−1.88 to −1.07<0.001 **
To what extent do you think COVID-19 poses a risk to you personally? (reference: Major risk)
 No risk at all/minor risk−1.04−0.13−1.66 to −0.42<0.001 **
 Moderate risk−0.80−0.10−1.36 to −0.24<0.001 **
 Significant risk−0.44−0.05−0.95 to 0.070.025
Do you personally know anyone (excluding yourself) who has had COVID-19? (reference: No)0.440.050.1 to 0.780.001 *
Have undertaken at least one behavioral change due to COVID-191.390.050.11 to 2.680.005 *
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Dafogianni, C.; Mangoulia, P.; Pappa, D.; Xanthopoulou, P.; Koutelekos, I.; Zografakis-Sfakianakis, M.; Ferentinou, E.; Fountouki, A.; Drakopoulou, M.; Giga, A.; et al. COVID-19 Vaccination Intention Associated with Behaviors towards Protection and Perceptions Regarding the Pandemic. J. Pers. Med. 2022, 12, 295. https://doi.org/10.3390/jpm12020295

AMA Style

Dafogianni C, Mangoulia P, Pappa D, Xanthopoulou P, Koutelekos I, Zografakis-Sfakianakis M, Ferentinou E, Fountouki A, Drakopoulou M, Giga A, et al. COVID-19 Vaccination Intention Associated with Behaviors towards Protection and Perceptions Regarding the Pandemic. Journal of Personalized Medicine. 2022; 12(2):295. https://doi.org/10.3390/jpm12020295

Chicago/Turabian Style

Dafogianni, Chrysoula, Polyxeni Mangoulia, Despoina Pappa, Panagiota Xanthopoulou, Ioannis Koutelekos, Mixalis Zografakis-Sfakianakis, Eftychia Ferentinou, Antigoni Fountouki, Marianna Drakopoulou, Anna Giga, and et al. 2022. "COVID-19 Vaccination Intention Associated with Behaviors towards Protection and Perceptions Regarding the Pandemic" Journal of Personalized Medicine 12, no. 2: 295. https://doi.org/10.3390/jpm12020295

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop